Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words '5-HT1C' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 112 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sugimoto, Y; Yoshikawa, T; Noma, T; Yamada, J
      The 5-HT2C/2B receptor agonist m-chlorophenylpiperazine (mCPP) inhibits 2-deoxy-D-glucose (2-DG)-induced hyperphagia in rats

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    2. Marazziti, D; Ori, M; Nardini, M; Rossi, A; Nardi, I; Cassano, GB
      mRNA expression of serotonin receptors of type 2C and 5A in human resting lymphocytes

      NEUROPSYCHOBIOLOGY
    3. Ichikawa, J; Dai, J; Meltzer, HY
      DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release

      BRAIN RESEARCH
    4. Goetz, CG; Vu, TQ; Carvey, PM; Leurgans, S
      Posthypoxic myoclonus in the rat: Natural history, stability, and serotonergic influences

      MOVEMENT DISORDERS
    5. Fiorica-Howells, E; Maroteaux, L; Gershon, MD
      Serotonin and the 5-HT2B receptor in the development of enteric neurons

      JOURNAL OF NEUROSCIENCE
    6. Schreiber, R; Selbach, K; Asmussen, M; Hesse, D; De Vry, J
      Effects of serotonin(1/2) receptor agonists on dark-phase food and water intake in rats

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    7. Imbrici, P; Tucker, SJ; D'Adamo, MC; Pessia, M
      Role of receptor protein tyrosine phosphatase alpha (RPTP alpha) and tyrosine phosphorylation in the serotonergic inhibition of voltage-dependent potassium channels

      PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
    8. Cryan, JF; Lucki, I
      Antidepressant-like behavioral effects mediated by 5-hydroxytryptamine(2C)receptors

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    9. Yamada, J; Sugimoto, Y
      The 5-HT2C/2B receptor agonist, m-chlorophenylpiperazine, increases plasmaglucagon levels in rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    10. Di Matteo, V; Di Mascio, M; Di Giovanni, G; Esposito, E
      Acute administration of amitriptyline and mianserin increases dopamine release in the rat nucleus accumbens: possible involvement of serotonin(2C) receptors

      PSYCHOPHARMACOLOGY
    11. Marazziti, D; Rossi, A; Giannaccini, G; Zavaglia, KM; Dell'Osso, L; Lucacchini, A; Cassano, GB
      Distribution and characterization of [H-3]mesulergine binding in human brain postmortem

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    12. Melis, MR; Argiolas, A
      Yawning: role of hypothalamic paraventricular nitric oxide

      ACTA PHARMACOLOGICA SINICA
    13. Di Matteo, V; Di Giovanni, G; Di Mascio, M; Esposito, E
      SB 242 084, a selective serotonin(2C) receptor antagonist, increases dopaminergic transmission in the mesolimbic system

      NEUROPHARMACOLOGY
    14. Hurley, JH; Bloem, LJ; Pavalko, F; Liu, J; Tian, MT; Simon, JR; Yu, L
      Structure-function studies of the eighth hydrophobic domain of a serotoninreceptor

      JOURNAL OF NEUROCHEMISTRY
    15. Kennaway, DJ; Moyer, RW
      MK-801 administration blocks the effects of a 5-HT2A/2C agonist on melatonin rhythmicity and c-fos induction in the suprachiasmatic nucleus

      BRAIN RESEARCH
    16. JENCK F; MOREAU JL; BERENDSEN HHG; BEES M; BROEKKAMP CLE; MARTIN JR; WICHMANN J; VANDELFT AML
      ANTIAVERSIVE EFFECTS OF 5HT(2C) RECEPTOR AGONISTS AND FLUOXETINE IN AMODEL OF PANIC-LIKE ANXIETY IN RATS

      European neuropsychopharmacology
    17. WALLIS CJ; LAL H
      A DISCRIMINATIVE STIMULUS PRODUCED BY 1-(3-CHLOROPHENYL)PIPERAZINE (MCPP) AS A PUTATIVE ANIMAL-MODEL OF ANXIETY

      Progress in neuro-psychopharmacology & biological psychiatry
    18. MIJNSTER MJ; GALISDEGRAAF Y; VOORN P
      SEROTONERGIC REGULATION OF NEUROPEPTIDE AND GLUTAMIC-ACID DECARBOXYLASE MESSENGER-RNA LEVELS IN THE RAT STRIATUM AND GLOBUS-PALLIDUS - STUDIES WITH FLUOXETINE AND DOI

      Molecular brain research
    19. WELSH SE; KACHELRIES WJ; ROMANO AG; SIMANSKY KJ; HARVEY JA
      EFFECTS OF LSD, RITANSERIN, 8-OH-DPAT, AND LISURIDE ON CLASSICAL-CONDITIONING IN THE RABBIT

      Pharmacology, biochemistry and behavior
    20. MOORMAN JM; LESLIE RA
      PARADOXICAL EFFECTS OF LITHIUM ON SEROTONERGIC RECEPTOR FUNCTION - ANIMMUNOCYTOCHEMICAL, BEHAVIORAL AND AUTORADIOGRAPHIC STUDY

      Neuropharmacology
    21. DIMATTEO V; DIGIOVANNI G; DIMASCIO M; ESPOSITO E
      SELECTIVE BLOCKADE OF SEROTONIN(2C 2B) RECEPTORS ENHANCES DOPAMINE RELEASE IN THE RAT NUCLEUS-ACCUMBENS/

      Neuropharmacology
    22. BROMIDGE SM; DABBS S; DAVIES DT; DUCKWORTH DM; FORBES IT; HAM P; JONES GE; KING FD; SAUNDERS DV; STARR S; THEWLIS KM; WYMAN PA; BLANEY FE; NAYLOR CB; BAILEY F; BLACKBURN TP; HOLLAND V; KENNETT GA; RILEY GJ; WOOD MD
      NOVEL AND SELECTIVE 5-HT2C 2B RECEPTOR ANTAGONISTS AS POTENTIAL ANXIOLYTIC AGENTS - SYNTHESIS, QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS, AND MOLECULAR MODELING OF SUBSTITUTED 1-(3-PYRIDYLCARBAMOYL)INDOLINES/

      Journal of medicinal chemistry
    23. ARGIOLAS A; MELIS MR
      THE NEUROPHARMACOLOGY OF YAWNING

      European journal of pharmacology
    24. KAPLAN JM; SONG S; GRILL HJ
      SEROTONIN RECEPTORS IN THE CAUDAL BRAIN-STEM ARE NECESSARY AND SUFFICIENT FOR THE ANORECTIC EFFECT OF PERIPHERALLY ADMINISTERED MCPP

      Psychopharmacology
    25. BILKEIGORZO A; GYERTYAN I; LEVAY G
      MCPP-INDUCED ANXIETY IN THE LIGHT-DARK BOX IN RATS - A NEW METHOD FORSCREENING ANXIOLYTIC ACTIVITY

      Psychopharmacology
    26. MEERT TF; MELIS W; AERTS N; CLINCKE G
      ANTAGONISM OF META-CHLOROPHENYLPIPERAZINE-INDUCED INHIBITION OF EXPLORATORY ACTIVITY IN AN EMERGENCE PROCEDURE, THE OPEN-FIELD TEST, IN RATS

      Behavioural pharmacology
    27. SHARMA A; PUNHANI T; FONE KCF
      DISTRIBUTION OF THE 5-HYDROXYTRYPTAMINE(2C) RECEPTOR PROTEIN IN ADULT-RAT BRAIN AND SPINAL-CORD DETERMINED USING A RECEPTOR-DIRECTED ANTIBODY - EFFECT OF 5,7-DIHYDROXYTRYPTAMINE

      Synapse
    28. MELIS MR; ARGIOLAS A
      ROLE OF CENTRAL NITRIC-OXIDE IN THE CONTROL OF PENILE ERECTION AND YAWNING

      Progress in neuro-psychopharmacology & biological psychiatry
    29. BUCKLAND PR; DSOUZA U; MAHER NA; MCGUFFIN P
      THE EFFECTS OF ANTIPSYCHOTIC-DRUGS ON THE MESSENGER-RNA LEVELS OF SEROTONIN 5HT(2A) AND 5HT(2C) RECEPTORS

      Molecular brain research
    30. KELLEY BM; PORTER JH
      THE ROLE OF MUSCARINIC CHOLINERGIC RECEPTORS IN THE DISCRIMINATIVE STIMULUS PROPERTIES OF CLOZAPINE IN RATS

      Pharmacology, biochemistry and behavior
    31. NEWTON RA; ELLIOTT JM
      MIANSERIN-INDUCED DOWN-REGULATION OF HUMAN 5-HYDROXYTRYPTAMINE(2A) AND 5-HYDROXYTRYPTAMINE(2C) RECEPTORS STABLY EXPRESSED IN THE HUMAN NEUROBLASTOMA CELL-LINE SH-SY5Y

      Journal of neurochemistry
    32. MELIS MR; SUCCU S; IANNUCCI U; ARGIOLAS A
      N-METHYL-D-ASPARTIC ACID-INDUCED PENILE ERECTION AND YAWNING - ROLE OF HYPOTHALAMIC PARAVENTRICULAR NITRIC-OXIDE

      European journal of pharmacology
    33. LEVITAN RD; KAPLAN AS; JOFFE RT; LEVITT AJ; BROWN GM
      HORMONAL AND SUBJECTIVE RESPONSES TO INTRAVENOUS META-CHLOROPHENYLPIPERAZINE IN BULIMIA-NERVOSA

      Archives of general psychiatry
    34. GEORGE DT; BENKELFAT C; RAWLINGS RR; ECKARDT MJ; PHILLIPS MJ; NUTT DJ; WYNNE D; MURPHY DL; LINNOILA M
      BEHAVIORAL AND NEUROENDOCRINE RESPONSES TO M-CHLOROPHENYLPIPERAZINE IN SUBTYPES OF ALCOHOLICS AND IN HEALTHY COMPARISON SUBJECTS

      The American journal of psychiatry
    35. MONGEAU R; MARSDEN CA
      EFFECT OF IMIPRAMINE TREATMENTS ON THE 5-HT1A-RECEPTOR-MEDIATED INHIBITION OF PANIC-LIKE BEHAVIORS IN RATS

      Psychopharmacology
    36. MELIS MR; SUCCU S; ARGIOLAS A
      DOPAMINE AGONISTS INCREASE NITRIC-OXIDE PRODUCTION IN THE PARAVENTRICULAR NUCLEUS OF THE HYPOTHALAMUS - CORRELATION WITH PENILE ERECTION AND YAWNING

      European journal of neuroscience
    37. MOREAU JL; BOS M; JENCK F; MARTIN JR; MORTAS P; WICHMANN J
      5HT(2C) RECEPTOR AGONISTS EXHIBIT ANTIDEPRESSANT-LIKE PROPERTIES IN THE ANHEDONIA MODEL OF DEPRESSION IN RATS

      European neuropsychopharmacology
    38. EBERLEWANG K; LUCKI I; CHESSELET MF
      A ROLE FOR THE SUBTHALAMIC NUCLEUS IN 5-HT2C-INDUCED ORAL DYSKINESIA

      Neuroscience
    39. MOORMAN JM; LESLIE RA
      P-CHLOROAMPHETAMINE INDUCES C-FOS IN RAT-BRAIN - A STUDY OF SEROTONIN(2A 2C) RECEPTOR FUNCTION/

      Neuroscience
    40. HEDGES DW; REIMHERR FW; STRONG RE; HALLS CH; RUST C
      AN OPEN TRIAL OF NEFAZODONE IN ADULT PATIENTS WITH GENERALIZED ANXIETY DISORDER

      Psychopharmacology bulletin
    41. WESTPHAL RS; SANDERSBUSH E
      DIFFERENCES IN AGONIST-INDEPENDENT AND AGONIST-DEPENDENT 5-HYDROXYTRYPTAMINE(2C) RECEPTOR-MEDIATED CELL-DIVISION

      Molecular pharmacology
    42. AUDIA JE; EVRARD DA; MURDOCH GR; DROSTE JJ; NISSEN JS; SCHENCK KW; FLUDZINSKI P; LUCAITES VL; NELSON DL; COHEN ML
      POTENT, SELECTIVE TETRAHYDRO-BETA-CARBOLINE ANTAGONISTS OF THE SEROTONIN 2B (5HT(2B)) CONTRACTILE RECEPTOR IN THE RAT STOMACH FUNDUS

      Journal of medicinal chemistry
    43. WONG G; KUOPPAMAKI M; HIETALA J; LUDDENS H; SYVALAHTI E; KORPI ER
      EFFECTS OF CLOZAPINE METABOLITES AND CHRONIC CLOZAPINE TREATMENT ON RAT-BRAIN GABA(A) RECEPTORS

      European journal of pharmacology
    44. MAZZOLAPOMIETTO P; AULAKH CS; MURPHY DL
      NMDA RECEPTOR ANTAGONISTS BLOCK DEVELOPMENT OF TOLERANCE TO M-CPP-INDUCED INCREASES IN ACTH CONCENTRATIONS IN RATS

      European journal of pharmacology
    45. SUGIMOTO Y; YAMADA J; YOSHIKAWA T; HORISAKA K
      EFFECTS OF THE 5-HT2C 2B RECEPTOR AGONIST 1-(3-CHLOROPHENYL)PIPERAZINE ON PLASMA-GLUCOSE LEVELS OF RATS/

      European journal of pharmacology
    46. KENNETT GA; WOOD MD; BRIGHT F; CILIA J; PIPER DC; GAGER T; THOMAS D; BAXTER GS; FORBES IT; HAM P; BLACKBURN TP
      IN-VITRO AND IN-VIVO PROFILE OF SB-206553, A POTENT 5-HT2C 5-HT2B RECEPTOR ANTAGONIST WITH ANXIOLYTIC-LIKE PROPERTIES/

      British Journal of Pharmacology
    47. DURSUN SN; HANDLEY SL
      SIMILARITIES IN THE PHARMACOLOGY OF SPONTANEOUS AND DOI-INDUCED HEAD SHAKES SUGGEST 5HT(2A) RECEPTORS ARE ACTIVE UNDER PHYSIOLOGICAL CONDITIONS

      Psychopharmacology
    48. BECKETT SRG; ASPLEY S; GRAHAM M; MARSDEN CA
      PHARMACOLOGICAL MANIPULATION OF ULTRASOUND INDUCED DEFENSE BEHAVIOR IN THE RAT

      Psychopharmacology
    49. LAPPALAINEN J; ZHANG L; DEAN M; OZ M; OZAKI N; YU DH; VIRKKUNEN M; WEIGHT F; LINNOILA M; GOLDMAN D
      IDENTIFICATION, EXPRESSION, AND PHARMACOLOGY OF A CYS(23)-SER(23) SUBSTITUTION IN THE HUMAN 5-HT2C RECEPTOR GENE (HTR2C)

      Genomics
    50. RICK CE; STANFORD IM; LACEY MG
      EXCITATION OF RAT SUBSTANTIA-NIGRA PARS RETICULATA NEURONS BY 5-HYDROXYTRYPTAMINE IN-VITRO - EVIDENCE FOR A DIRECT ACTION MEDIATED BY 5-HYDROXYTRYPTAMINE(2C) RECEPTORS

      Neuroscience
    51. ONAIVI ES; BISHOPROBINSON C; DARMANI NA; SANDERSBUSH E
      BEHAVIORAL-EFFECTS OF (+ -)-1-(2,5-DIMETHOXY-4-IODOPHENYL)-2-AMINOPROPANE, (DOI) IN THE ELEVATED PLUS-MAZE TEST/

      Life sciences
    52. ABRAMOWSKI D; STAUFENBIEL M
      IDENTIFICATION OF THE 5-HYDROXYTRYPTAMINE(2C) RECEPTOR AS A 60-KDA N-GLYCOSYLATED PROTEIN IN CHOROID PLEXUS AND HIPPOCAMPUS

      Journal of neurochemistry
    53. KAUFMAN MJ; HARTIG PR; HOFFMAN BJ
      SEROTONIN 5-HT2C RECEPTOR STIMULATES CYCLIC-GMP FORMATION IN CHOROID-PLEXUS

      Journal of neurochemistry
    54. NOZULAK J; KALKMAN HO; FLOERSHEIM P; HOYER D; SCHOEFFTER P; BUERKI HR
      YDRO-7H-10-METHYLINDOLO[1,7-BC][2,6]-NAPHTHYRIDINE - A 5-HT(2C())2B) RECEPTOR ANTAGONIST WITH LOW 5-HT(2A) RECEPTOR AFFINITY/

      Journal of medicinal chemistry
    55. PRISCO S; ESPOSITO E
      DIFFERENTIAL-EFFECTS OF ACUTE AND CHRONIC FLUOXETINE ADMINISTRATION ON THE SPONTANEOUS ACTIVITY OF DOPAMINERGIC-NEURONS IN THE VENTRAL TEGMENTAL AREA

      British Journal of Pharmacology
    56. MELTZER HY; MAES M
      EFFECT OF PINDOLOL PRETREATMENT ON MK-212-INDUCED PLASMA-CORTISOL ANDPROLACTIN RESPONSES IN NORMAL MEN

      Biological psychiatry
    57. SHARPLEY AL; COWEN PJ
      EFFECT OF PHARMACOLOGICAL TREATMENTS ON THE SLEEP OF DEPRESSED-PATIENTS

      Biological psychiatry
    58. MOLEWIJK HE; VANDERPOEL AM; OLIVIER B
      THE AMBIVALENT BEHAVIOR STRETCHED APPROACH POSTURE IN THE RAT AS A PARADIGM TO CHARACTERIZE ANXIOLYTIC DRUGS

      Psychopharmacology
    59. PANOCKA I; CICCOCIOPPO R; MOSCA M; POLIDORI C; MASSI M
      EFFECTS OF THE DOPAMINE D-1 RECEPTOR ANTAGONIST SCH-39166 ON THE INGESTIVE BEHAVIOR OF ALCOHOL-PREFERRING RATS

      Psychopharmacology
    60. GOTZES F; BALFANZ S; BAUMANN A
      PRIMARY STRUCTURE AND FUNCTIONAL-CHARACTERIZATION OF A DROSOPHILA DOPAMINE-RECEPTOR WITH HIGH HOMOLOGY TO HUMAN D(1 5) RECEPTORS/

      Receptors & channels
    61. BREWERTON TD; MURPHY DL; JIMERSON DC
      TESTMEAL RESPONSES FOLLOWING M-CHLOROPHENYLPIPERAZINE AND L-TRYPTOPHAN IN BULIMICS AND CONTROLS

      Neuropsychopharmacology
    62. PRANZATELLI MR; RAZI P
      DRUG-INDUCED REGULATION OF [I-125] IODOCYANOPINDOLOL-LABELED 5-HYDROXYTRYPTAMINE(1B) RECEPTOR-BINDING SITES IN THE CENTRAL-NERVOUS-SYSTEM

      Neuropsychopharmacology
    63. NASH JF; ROTH BL; BRODKIN JD; NICHOLS DE; GUDELSKY GA
      EFFECT OF THE R(-) AND S(-CELLS EXPRESSING 5-HT2A OR 5-HT2C RECEPTORS() ISOMERS OF MDA AND MDMA ON PHOSPHOTIDYL INOSITOL TURNOVER IN CULTURED)

      Neuroscience letters
    64. JENCK F; MOREAU JL; MUTEL V; MARTIN JR
      BRAIN 5-HT1C RECEPTORS AND ANTIDEPRESSANTS

      Progress in neuro-psychopharmacology & biological psychiatry
    65. GILLON JY; VITTE PA; LEMONNIER F; KATO G
      BIOCHEMICAL-EVIDENCE FOR THE INVOLVEMENT OF CENTRAL SEROTONERGIC NEUROTRANSMISSION IN THE ACTION OF THE ANTIDEPRESSANT DRUG MEDIFOXAMINE

      Drug development research
    66. AULAKH CS; TOLLIVER T; WOZNIAK KM; HILL JL; MURPHY DL
      FUNCTIONAL AND BIOCHEMICAL-EVIDENCE FOR ALTERED SEROTONERGIC FUNCTIONIN THE FAWN-HOODED RAT STRAIN

      Pharmacology, biochemistry and behavior
    67. LIGHTOWLER S; KENNETT GA; WILLIAMSON IJR; BLACKBURN TP; TULLOCH IF
      ANXIOLYTIC-LIKE EFFECT OF PAROXETINE IN A RAT SOCIAL-INTERACTION TEST

      Pharmacology, biochemistry and behavior
    68. AULAKH CS; HILL JL; MURPHY DL
      LITHIUM TREATMENT RESTORES CLONIDINES EFFECT IN AN ANIMAL-MODEL OF DEPRESSION

      Pharmacology, biochemistry and behavior
    69. MARTIN GR; HUMPHREY PPA
      RECEPTORS FOR 5-HYDROXYTRYPTAMINE - CURRENT PERSPECTIVES ON CLASSIFICATION AND NOMENCLATURE

      Neuropharmacology
    70. SPURLOCK G; BUCKLAND P; ODONOVAN M; MCGUFFIN P
      LACK OF EFFECT OF ANTIDEPRESSANT DRUGS ON THE LEVELS OF MESSENGER-RNAS ENCODING SEROTONERGIC RECEPTORS, SYNTHETIC ENZYMES AND 5HT TRANSPORTER

      Neuropharmacology
    71. GIBSON EL; BARNFIELD AMC; CURZON G
      EVIDENCE THAT MCPP-INDUCED ANXIETY IN THE PLUS-MAZE IS MEDIATED BY POSTSYNAPTIC 5-HT2C RECEPTORS BUT NOT BY SYMPATHOMIMETIC EFFECTS

      Neuropharmacology
    72. BERG KA; CLARKE WP; SAILSTAD C; SALTZMAN A; MAAYANI S
      SIGNAL-TRANSDUCTION DIFFERENCES BETWEEN 5-HYDROXYTRYPTAMINE TYPE 2A AND TYPE 2C RECEPTOR SYSTEMS

      Molecular pharmacology
    73. PRISCO S; PAGANNONE S; ESPOSITO E
      SEROTONIN-DOPAMINE INTERACTION IN THE RAT VENTRAL TEGMENTAL AREA - ANELECTROPHYSIOLOGICAL STUDY IN-VIVO

      The Journal of pharmacology and experimental therapeutics
    74. AULAKH CS; MAZZOLAPOMIETTO P; WOZNIAK KM; HILL JL; MURPHY DL
      EVIDENCE THAT 5-DIMETHOXY-4-METHYLPHENYL)-2-AMINOPROPANE-INDUCED HYPOPHAGIA AND HYPERTHERMIA IN RATS IS MEDIATED BY SEROTONIN-2A RECEPTORS

      The Journal of pharmacology and experimental therapeutics
    75. SALZMAN SK; KELLY G; CHAVIN J; WANG L; PUNIAK MA; AGRESTA CA; AZIM S
      CHARACTERIZATION OF MIANSERIN NEUROPROTECTION IN EXPERIMENTAL SPINAL TRAUMA - DOSE ROUTE RESPONSE AND LATE TREATMENT/

      The Journal of pharmacology and experimental therapeutics
    76. ROTH BL; CRAIGO SC; CHOUDHARY MS; ULUER A; MONSMA FJ; SHEN Y; MELTZER HY; SIBLEY DR
      BINDING OF TYPICAL AND ATYPICAL ANTIPSYCHOTIC AGENTS TO 5-HYDROXYTRYPTAMINE-6 AND 5-HYDROXYTRYPTAMINE-7 RECEPTORS

      The Journal of pharmacology and experimental therapeutics
    77. NICHOLS DE; FRESCAS S; MARONALEWICKA D; HUANG XM; ROTH BL; GUDELSKY GA; NASH JF
      IMETHOXY-4-(TRIFLUOROMETHYL)PHENYL)-2-AMINOPROPANE - A POTENT SEROTONIN 5-HT2A 2C AGONIST/

      Journal of medicinal chemistry
    78. BARKER EL; WESTPHAL RS; SCHMIDT D; SANDERSBUSH E
      CONSTITUTIVELY ACTIVE 5-HYDROXYTRYPTAMINE(2C) RECEPTORS REVEAL NOVEL INVERSE AGONIST ACTIVITY OF RECEPTOR LIGANDS

      The Journal of biological chemistry
    79. HULIHANGIBLIN BA; PARK YD; AULAKH CS
      DIFFERENTIAL-EFFECTS OF CHRONIC ANTIDEPRESSANT TREATMENT ON 5-HT1C RECEPTOR-BINDING SITES IN WISTAR RAT-BRAIN

      European journal of pharmacology
    80. CHENG CHK; COSTALL B; KELLY ME; NAYLOR RJ
      ACTIONS OF 5-HYDROXYTRYPTOPHAN TO INHIBIT AND DISINHIBIT MOUSE BEHAVIOR IN THE LIGHT DARK TEST/

      European journal of pharmacology
    81. KUOPPAMAKI M; PALVIMAKI EP; SYVALAHTI E; HIETALA J
      5-HT1C RECEPTOR-MEDIATED PHOSPHOINOSITIDE HYDROLYSIS IN THE RAT CHOROID-PLEXUS AFTER CHRONIC TREATMENT WITH CLOZAPINE

      European journal of pharmacology
    82. KENNETT GA; WOOD MD; GLEN A; GREWAL S; FORBES I; GADRE A; BLACKBURN TP
      IN-VIVO PROPERTIES OF SB 200646A, A 5-HT2C 2B RECEPTOR ANTAGONIST/

      British Journal of Pharmacology
    83. WALSH AES; SMITH KA; OLDMAN AD; WILLIAMS C; GOODALL EM; COWEN PJ
      M-CHLOROPHENYLPIPERAZINE DECREASES FOOD-INTAKE IN A TEST MEAL

      Psychopharmacology
    84. MELTZER HY; MAES M
      EFFECT OF PINDOLOL ON THE L-5-HTP-INDUCED INCREASE IN PLASMA PROLACTIN AND CORTISOL CONCENTRATIONS IN MAN

      Psychopharmacology
    85. KENNETT GA; PITTAWAY K; BLACKBURN TP
      EVIDENCE THAT 5-HT2C RECEPTOR ANTAGONISTS ARE ANXIOLYTIC IN THE RAT GELLER-SEIFTER MODEL OF ANXIETY

      Psychopharmacology
    86. TERRY P; KATZ JL
      A COMPARISON OF THE EFFECTS OF THE D-1 RECEPTOR ANTAGONISTS SCH-23390AND SCH-39166 ON SUPPRESSION OF FEEDING-BEHAVIOR BY THE D-1 AGONIST SKF38393

      Psychopharmacology
    87. KITCHENER SJ; DOURISH CT
      AN EXAMINATION OF THE BEHAVIORAL SPECIFICITY OF HYPOPHAGIA INDUCED BY5-HT1B, 5-HT1C AND 5-HT2 RECEPTOR AGONISTS USING THE POSTPRANDIAL SATIETY SEQUENCE IN RATS

      Psychopharmacology
    88. SIMON P; BERTRAND J; COSTENTIN J
      5-HT1A RECEPTOR BLOCKADE INCREASES PENILE ERECTIONS INDUCED BY INDIRECT SEROTONIN AGONISTS

      NeuroReport
    89. SANCHEZ C
      EFFECT OF SEROTONERGIC DRUGS ON FOOTSHOCK-INDUCED ULTRASONIC VOCALIZATION IN ADULT MALE-RATS

      Behavioural pharmacology
    90. REZAZADEH SM; PRATHER PL; LAL H
      SENSITIZATION TO 5-HT(1C) RECEPTOR AGONIST IN RATS OBSERVED FOLLOWINGWITHDRAWAL FROM CHRONIC ETHANOL

      Alcohol
    91. ROCHA B; DISCALA G; RIGO M; HOYER D; SANDNER G
      EFFECT OF 5,7-DIHYDROXYTRYPTAMINE LESION ON MIANSERIN-INDUCED CONDITIONED PLACE AVERSION AND ON 5-HYDROXYTRYPTAMINE(1C) RECEPTORS IN THE RAT-BRAIN

      Neuroscience
    92. CLIFTON PG; BARNFIELD AM; CURZON G
      EFFECTS OF FOOD-DEPRIVATION AND MCPP TREATMENT ON THE MICROSTRUCTURE OF INGESTIVE BEHAVIOR OF MALE AND FEMALE RATS

      JOURNAL OF PSYCHOPHARMACOLOGY
    93. KAHN RS; DAVIDSON M
      SEROTONIN RECEPTOR RESPONSIVITY IN SCHIZOPHRENIA

      International clinical psychopharmacology
    94. GONG L; KOSTRZEWA RM; KALBFLEISCH JH
      MIF-1 FAILS TO MODIFY AGONIST-INDUCED ORAL ACTIVITY IN NEONATAL 6-OHDA-TREATED RATS

      Peptides
    95. GRAEFF FG; SILVEIRA MCL; NOGUEIRA RL; AUDI EA; OLIVEIRA RMW
      ROLE OF THE AMYGDALA AND PERIAQUEDUCTAL GRAY IN ANXIETY AND PANIC

      Behavioural brain research
    96. JOHNSON RG; FIORELLA D; RABIN RA
      EFFECTS OF CHRONIC COCAINE ADMINISTRATION ON THE SEROTONERGIC SYSTEM IN THE RAT-BRAIN

      Pharmacology, biochemistry and behavior
    97. WINTER JC; RABIN RA
      DISCRIMINATIVE STIMULUS PROPERTIES OF M-CHLOROPHENYLPIPERAZINE

      Pharmacology, biochemistry and behavior
    98. BAUMANN MH; RUTTER JJ; AUERBACH SB
      INTRAVENOUS ADMINISTRATION OF THE SEROTONIN AGONIST M-CHLOROPHENYLPIPERAZINE (MCPP) INCREASES EXTRACELLULAR SEROTONIN IN THE DIENCEPHALON OF AWAKE RATS

      Neuropharmacology
    99. AULAKH CS; HILL JL; MURPHY DL
      DIFFERENTIAL EFFECT OF SHORT-TERM AND LONG-TERM LITHIUM TREATMENT ON M-CPP-INDUCED NEUROENDOCRINE CHANGES IN RATS

      Neuroendocrinology
    100. BARKER EL; SANDERSBUSH E
      5-HYDROXYTRYPTAMINE1C RECEPTOR DENSITY AND MESSENGER-RNA LEVELS IN CHOROID-PLEXUS EPITHELIAL-CELLS AFTER TREATMENT WITH MIANSERIN AND (-)-1-(4-BROMO-2,5-DIMETHOXYPHENYL)-2-AMINOPROPANE

      Molecular pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 09:30:26